PubMed چکیده/رکورد

Locally Deployed Large Language Models for AI-Assisted Outpatient Prescription Review: Crossover Study.

استودیوی صوتی مقاله

پخش حرفه‌ای فارسی و انگلیسی

در حال بررسی نسخه‌های صوتی ذخیره‌شده…

صوت تولیدشده با هوش مصنوعی است. برای کاربرد علمی یا درمانی، متن و منبع اصلی را بررسی کنید.
خواندن هوشمند فارسی و انگلیسی در حال آماده‌سازی صداهای مرورگر…
تنظیم صدای طبیعی و سرعت

صداهایی که در نامشان «Natural»، «Neural» یا «Online» دیده می‌شود معمولاً طبیعی‌ترند. انتخاب صدا به صداهای نصب‌شده در ویندوز و مرورگر شما بستگی دارد.

چکیده اصلی

BACKGROUND: Pharmacists' prescription review is key to medication safety, but rising numbers of outpatient prescriptions and expanding formularies leave less time per case, increasing error risk. Large language models (LLMs) show promise, yet two barriers hinder routine use: first, most systems rely on cloud-based commercial models, risking data breaches by transmitting protected patient information externally, and second, retrieval-augmented generation (RAG) pipelines used to reduce hallucinations depend on complex text vectorization and vector databases, which hospitals with limited IT resources struggle to build and maintain. OBJECTIVE: This study aimed to evaluate the feasibility and usefulness of a locally deployed, knowledge-augmented LLM as a decision-support tool for pharmacist-led outpatient prescription review. METHODS: The open-source Qwen3-14B model was deployed on a hospital intranet server using the Ollama framework. A structured knowledge base derived from drug package inserts served as the principal reference and supported lightweight knowledge augmentation through exact-match injection. A 2-period crossover design was used: 2 pharmacists independently reviewed 213 outpatient prescriptions under both unaided and AI-assisted conditions, yielding paired unaided and collaborative results for each prescription. Plain AI review and knowledge-augmented AI review were also run on the same 213-prescription test set to quantify hallucination rates, and stand-alone AI performance was assessed against the reference standard. The reference standard was established by independent consensus between two supervising pharmacists, with disagreements adjudicated by a deputy chief pharmacist. Accuracy, sensitivity, and specificity were compared between conditions using paired McNemar tests, and review time was compared using the Wilcoxon signed-rank test. RESULTS: Overall review accuracy was 97.2% (207/213, 95% CI 94.0%-98.7%) in the human-AI collaborative condition vs 82.6% (176/213, 95% CI 77.0%-87.1%) in the pharmacist-alone condition (P<.001). Sensitivity was 98% (61/62) vs 55% (34/62), and the false-negative rate fell from 45% to 2% (P<.001). Specificity did not differ significantly (146/151, 96.7% vs 142/151, 94%; P=.29). Knowledge augmentation reduced the model hallucination rate from 19.7% (42/213 prescriptions) to 4.7% (10/213), an absolute reduction of 15.0 percentage points (relative reduction 76.2%; P<.001). Collaborative review reduced the mean per-prescription review time from 2.33 (SD 0.97) to 1.12 (SD 0.49) minutes (approximately 51.9% reduction; Wilcoxon signed-rank Z=-12.65; P<.001; r=0.87). CONCLUSIONS: A locally deployed, knowledge-augmented LLM used as a pharmacist-supervised prescreening tool was associated with substantially higher accuracy and sensitivity in outpatient retrospective prescription review, while keeping all prescription data within the hospital network. Locally deployed open-source models may offer hospitals a privacy-preserving and practical route to AI-assisted pharmacy decision support.

متن کامل اصلی

متن در JumpToDate ذخیره نشده است.

برای بررسی دسترسی کتابخانه‌ای یا خرید، رکورد اصلی را باز کنید.

رفتن به منبع اصلی

کلیدواژه‌ها

Ollamahuman-AI collaborationhuman–artificial intelligence collaborationknowledge augmentationlarge language modelon-premise deploymentprescription review
در همین زیرشاخه

مقاله‌های مرتبط

PubMed2026

Real-world pharmacoclinical implementation of risdiplam under a national SMA protocol: A hospital pharmacy registry-based case series.

BACKGROUND: Spinal muscular atrophy (SMA) is a rare neuromuscular disorder treated with disease-modifying therapies such as risdiplam. In Spain, its use is regulated by a national pharmacoclinical protocol that requires structured monitoring. OBJECTIVES: To evaluate real-world use, protocol adherence and registry completeness of risdiplam in routine clinical practice. METHODS: A retrospective registry-based case series was conducted in…

PubMed2026

Sex Differences in Prescribing Patterns of Anticholinergics and β3-Adrenoceptor Agonists for Overactive Bladder: A Nationwide Study in Japan, FY2017-FY2024.

OBJECTIVES: Drug treatment for overactive bladder (OAB) is changing, with an increasing share of β3-adrenoceptor agonists relative to anticholinergics, but it is not known how far this change has progressed in older people, who are most vulnerable to the risks of anticholinergics. We examined the use of these drugs in Japan by age and sex, and analyzed changes in anticholinergic burden using a large database. METHODS: We analyzed outpa…

PubMed2026

ARMED: an Australian cohort retrospective observational study to understand motivations for switching and clinical outcomes of individuals switching to dolutegravir/lamivudine.

BACKGROUND: Although clinical trials and real-world studies demonstrate the efficacy and tolerability of dolutegravir and lamivudine (DTG + 3TC), Australian real-world evidence remains limited despite differences in access to health care and prescribing context. Here, we present the motivations for switching to DTG/3TC (a fixed-dose, single-tablet regimen) and treatment outcomes. METHODS: We performed a retrospective, observational ana…

PubMed2026

Antibiotic prescribing that aligns with a host-protein test at US acute care settings is associated with fewer subsequent hospitalisations.

BACKGROUND: Differentiating bacterial from viral infections in acute care is challenging, often leading to inappropriate antibiotic use. MeMed BV (MMBV) is a host-protein test integrating TNF-related apoptosis-inducing ligand, induced protein-10 and C-reactive protein to distinguish infection aetiology. We evaluated whether alignment between MMBV results and antibiotic prescribing is associated with downstream clinical outcomes and cos…